康科特股份有限公司 Approved
最後更新時間 2025/07/14 , 02:48 AM
最後更新時間 2025/07/14 , 02:48 AM
負責人
Liu,Jing-Yi
統一編號
25029519
成立日期
2009/09/10
資本額
NT$400,000,000
實收資本額
NT$333,333,340
股票代號
6518
電話
02-22545079
地址
12F, No. 266, Sec. 1, Wunhua Rd., Banqiao Dist., New Taipei City, 220, Taiwan
網站
董監事
姓名 職稱 持有股份 代表法人
Liu,Jing-Yi Chairman 40.00% BenQ Medical Technology Corporation
Yang,Hong-Pei Vice Chairman 40.00% BenQ Medical Technology Corporation
Guan,Xin-Bao Director 40.00% BenQ Medical Technology Corporation
Lin,Jia-Hong Director 40.00% BenQ Medical Technology Corporation
Liu,Fu-An Director 40.00% BenQ Medical Technology Corporation
Chen,Jian-Ding Director 17.16% ROYAL HENA INTERNATIONAL DEVELOPMENT CORP.
Ye,Shu-Ling Independent Director 0.00%
Li,Yi-Yu Independent Director 0.00%
Jiang,Jia-Yu Independent Director 0.00%
營業項目
  • Wholesale of Other Machinery and Equipment(464915)
  • Wholesale of Pharmaceutical and Medical Goods(457113)
  • 公司歷程
  • Change Capital to 400,000,000
    2022/01/12
  • Change Capital to 300,000,000
    2013/06/14
  • Change Capital to 70,000,000
    2013/04/02
  • Change Capital to 50,000,000
    2012/12/10
  • Change Capital to 20,000,000
    2012/03/03
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023 2022
    Operating income 889,845 833,202 889,205
    Operating cost 780,228 731,055 780,109
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 109,617 102,147 109,096
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 109,617 102,147 109,096
    Operating expenses 48,811 47,406 44,313
    Other gain (loss), net - - -
    Operating profit (loss) 60,806 54,741 64,783
    Non-operating income and expenses 1,644 -215 -560
    Net profit (loss) before tax 62,450 54,526 64,223
    Income tax expense (benefits) 12,880 11,782 13,583
    Net profit (loss) of ongoing business for the current period 49,570 42,744 50,640
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 49,570 42,744 50,640
    Other comprehensive profit (loss), net - - -
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 49,570 42,744 50,640
    Net profit (loss) attributable to owners of parent company 49,570 42,744 50,656
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - 0 -16
    Comprehensive profit (loss) attributable to owners of parent company 49,570 42,744 50,656
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - 0 -16
    Basic earnings per share (yuan) 1 1 1
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities 148,833 113,226 154,561
    Net cash inflows (outflows) from investing activities -92,325 -188,080 -110,314
    Net cash inflow (outflow) from financing activities -58,021 -60,797 3,866
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period -1,513 -135,651 48,113
    Beginning balance of cash and cash equivalents 111,260 246,911 198,798
    Ending balance of cash and cash equivalents 109,747 111,260 246,911
    項目 2024 2023 2022
    Current asset 630,998 638,341 678,167
    Non-current asset 532,795 513,392 497,493
    Total asset 1,163,793 1,151,733 1,175,660
    Current liability 285,527 282,539 298,720
    Non-current liability 181,003 188,168 165,341
    Total liability 466,530 470,707 464,061
    share capital 333,333 333,333 333,333
    Equity - secruity token - - -
    capital reserve 179,216 179,216 179,216
    retained earning 184,714 169,227 159,816
    Other equity 0 -750 -750
    Treasury stock - - -
    Total equity attributable to owners of parent company 697,263 681,026 671,615
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 0 0 39,984
    Total Equity 697,263 681,026 711,599
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 20 20 20
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • MedtraCare
  • 美怡康
  • 康樂源
  • 康科特
  • 康科特股份有限公司標章
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Payment order
    2020, 2024
  • Pay for the goods
    2024
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。